In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Rhein Biotech NV

Division of Dynavax Technologies Corp.

Latest From Rhein Biotech NV

Deals (04/2006)

European Biotechs Resort to Layoffs

Since redundancies in Europe are expensive and politically sensitive, companies have tended, where possible, to find other ways of cutting costs. The prolonged biotech winter is leaving many European biotechs with few options besides layoffs, however.
BioPharmaceutical Europe

Isotis and Modex Take the Offensive

With market capitalizations below €40 million, both Modex and IsoTis have lost investors' attention, and have products too small to drive sufficient growth internally. Merging won't solve their size problems immediately, but it gives them a better chance of making the external acquisitions that neither could afford alone.
BioPharmaceutical Europe

Long End of the Stick

Sustainable and increasingly focused, mid-sized vaccines companies are leading the way in European biotech, catalyzed by fears of bioterrorism and a re-emerging belief that prevention trumps cure, both practically and pharmaco-economically.
BioPharmaceutical Strategy
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • Dynavax Technologies Corp.
  • Senior Management
  • Contact Info
  • Rhein Biotech NV
    Phone: (49) 211 7 58 45 0
    Eichsfelder Strasse 11
    Düsseldorf, D-40595